• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫刺激复合物(ISCOM),一种用于包膜病毒膜蛋白抗原呈递的新型结构。

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

作者信息

Morein B, Sundquist B, Höglund S, Dalsgaard K, Osterhaus A

出版信息

Nature. 1984;308(5958):457-60. doi: 10.1038/308457a0.

DOI:10.1038/308457a0
PMID:6709052
Abstract

We describe here a novel type of immunostimulating complex, called 'iscom', in which virus membrane proteins are presented in a multimeric form. The matrix of the iscom is the glycoside Quil A (Spikoside; Iscotec AB), extracted from the bark of Quillaja saponaria Molina, which forms micelles at the critical micellar concentration of 0.03%. In micelle form, Quil A probably has regions accessible for hydrophobic interaction with the membrane proteins so that it can form complexes with them. Iscoms have been prepared with membrane proteins of para-influenza-3 (PI-3), measles and rabies viruses, and their immunizing potency tested in animals. In these experiments, iscoms prove to be at least 10 times more potent than micelles formed by aggregation of the membrane proteins alone. Iscoms of PI-3 and measles viruses also stimulate the formation of antibody to the fusion (F) protein, which is considered to be poorly immunogenic. No side effects of iscoms or of protein micelles have been observed.

摘要

我们在此描述一种新型免疫刺激复合物,称为“iscom”,其中病毒膜蛋白以多聚体形式呈现。iscom的基质是糖苷Quil A(Spikoside;Iscotec AB),从皂树(Quillaja saponaria Molina)的树皮中提取,在临界胶束浓度为0.03%时形成胶束。以胶束形式存在时,Quil A可能具有可与膜蛋白进行疏水相互作用的区域,从而能与它们形成复合物。已用副流感病毒3型(PI-3)、麻疹病毒和狂犬病病毒的膜蛋白制备了iscom,并在动物中测试了它们的免疫效力。在这些实验中,iscom被证明比仅由膜蛋白聚集形成的胶束效力至少高10倍。PI-3和麻疹病毒的iscom还能刺激针对融合(F)蛋白的抗体形成,而F蛋白被认为免疫原性较差。未观察到iscom或蛋白质胶束有副作用。

相似文献

1
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.免疫刺激复合物(ISCOM),一种用于包膜病毒膜蛋白抗原呈递的新型结构。
Nature. 1984;308(5958):457-60. doi: 10.1038/308457a0.
2
Influenza virus ISCOMs: biochemical characterization.
Vaccine. 1988 Feb;6(1):44-8. doi: 10.1016/0264-410x(88)90013-8.
3
Potentiation of the immune response by immunization with antigens in defined multimeric physical forms.
Vet Immunol Immunopathol. 1987 Dec;17(1-4):153-9. doi: 10.1016/0165-2427(87)90136-x.
4
Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes.
Vaccine. 1985 Jun;3(2):83-93. doi: 10.1016/0264-410x(85)90055-6.
5
[Isolation of polymeric glycoprotein complexes of enveloped viruses using the Quill A glycoside and a study of their immunogenic activity].
Vopr Virusol. 1987 May-Jun;32(3):312-7.
6
In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations.皂树三萜类制剂在体内和体外对IL-6的诱导作用。
Cytokine. 1997 Sep;9(9):682-7. doi: 10.1006/cyto.1997.0219.
7
Influence of Quil A on liposomal membranes.Quil A对脂质体膜的影响。
Int J Pharm. 2014 Nov 20;475(1-2):138-46. doi: 10.1016/j.ijpharm.2014.08.007. Epub 2014 Aug 6.
8
Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.用于免疫刺激复合物(ISCOM)基质的无毒皂树(Quillaja saponaria Molina)成分的佐剂活性。
Vaccine. 1995 Oct;13(14):1375-82. doi: 10.1016/0264-410x(95)00105-a.
9
Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.免疫刺激复合物(ISCOM)携带的抗原的内化以及在MHC I类或II类限制下的呈递。
Cell Immunol. 1998 Apr 10;185(1):30-8. doi: 10.1006/cimm.1998.1278.
10
Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.皂树皂苷和脂质在免疫刺激复合物基质及免疫刺激复合物中的分离与定量分析
Vaccine. 1995 Dec;13(17):1690-6. doi: 10.1016/0264-410x(95)00107-c.

引用本文的文献

1
Leaf Saponins of as Powerful Vaccine Adjuvants.作为强效疫苗佐剂的[植物名称]叶皂苷
Pharmaceutics. 2025 Jul 25;17(8):966. doi: 10.3390/pharmaceutics17080966.
2
Advances in vaccine adjuvant development and future perspectives.疫苗佐剂研发进展与未来展望
Drug Deliv. 2025 Dec;32(1):2517137. doi: 10.1080/10717544.2025.2517137. Epub 2025 Jun 19.
3
The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates.皂苷单磷酰脂质A纳米颗粒佐剂在非人灵长类动物中诱导出剂量依赖性的HIV疫苗反应。
J Clin Invest. 2025 Mar 4;135(8). doi: 10.1172/JCI185292. eCollection 2025 Apr 15.
4
ISCOM-type matrix from beta-escin and glycyrrhizin saponins.来源于七叶皂苷和甘草皂苷的免疫刺激复合物(ISCOM)型基质。
Heliyon. 2025 Jan 13;11(2):e41935. doi: 10.1016/j.heliyon.2025.e41935. eCollection 2025 Jan 30.
5
Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cells and macrophages.基于皂苷的佐剂摄取以及CD11b+树突状细胞和巨噬细胞对抗原交叉呈递的诱导作用。
NPJ Vaccines. 2025 Jan 22;10(1):15. doi: 10.1038/s41541-024-01056-y.
6
Recent Review on Biological Barriers and Host-Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies.精准给药中的生物屏障与宿主-材料界面的最新综述:生物材料工程促进更好治疗方法的进展
Pharmaceutics. 2024 Aug 16;16(8):1076. doi: 10.3390/pharmaceutics16081076.
7
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges.基于纳米平台的鼻腔内疫苗:当前进展和临床挑战。
ACS Nano. 2024 Sep 10;18(36):24650-24681. doi: 10.1021/acsnano.3c10797. Epub 2024 Aug 26.
8
Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses.皂苷纳米颗粒佐剂结合 Toll 样受体激动剂可诱导不同的免疫特征和有效的疫苗应答。
Sci Adv. 2024 Aug 9;10(32):eadn7187. doi: 10.1126/sciadv.adn7187. Epub 2024 Aug 7.
9
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds.通过在非胸腺依赖型 DNA 折纸支架上展示多价抗原来增强抗体反应。
Nat Commun. 2024 Jan 30;15(1):795. doi: 10.1038/s41467-024-44869-0.
10
Potential Immunoregulatory Mechanism of Plant Saponins: A Review.植物皂素的潜在免疫调节机制:综述。
Molecules. 2023 Dec 23;29(1):113. doi: 10.3390/molecules29010113.